Related Experiment Video
Updated: Jan 31, 2026
Evaluating the Function of the Foot Core System in the Elderly
Published on: March 11, 2022
Statin therapy in elderly patients
Insights
Statins offer significant cardiovascular benefits for the elderly, even those with frailty or disability. Careful consideration of comorbidities is essential for safe and effective management of dyslipidemia in seniors.
Area of Science:
- Gerontology
- Cardiology
- Pharmacology
Background:
- Elderly patients face complex cardiovascular changes and comorbidities, impacting drug response and adherence.
- Altered pharmacokinetics and pharmacodynamics in seniors necessitate cautious medication management.
- Cognitive impairment can further complicate adherence to treatment regimens.
Purpose of the Study:
- To evaluate the benefits and risks of statin therapy in elderly patients with cardiovascular disease.
- To emphasize the importance of individualized statin indication considering frailty and comorbidities.
- To highlight statins as high-priority medications for seniors with a life expectancy over 5 years.
Main Methods:
- Review of current literature on statin use in the elderly population.
- Analysis of factors influencing therapeutic response and adverse events in older adults.
- Assessment of the impact of comorbidities, frailty, and disability on statin efficacy and safety.
Main Results:
- Elderly individuals experience the greatest absolute benefit from cardiovascular treatment.
- Frail and disabled patients on statins show reduced mortality rates despite a higher risk of adverse effects.
- Statins provide proven benefits for seniors with a life expectancy exceeding 5 years.
Conclusions:
- Statins are beneficial for managing dyslipidemia and preventing cardiovascular events in the elderly.
- Individualized assessment of comorbidities, frailty, and disability is crucial for safe statin prescription.
- Statins should be considered a high-priority treatment for eligible seniors.
Abstract:
Cardiovascular events occur most frequently in patients at higher age groups. The elderly suffer not only more advanced and complex changes of cardiovascular system but, also, other chronic conditions. Moreover, compared to middle-age, different therapeutic response is often observed due to changes of pharmaco-kinetics and -dynamics; these patients use other medications, which may trigger drug interactions. The situation is further complicated by non-adherence related to frequent cognitive impairment. On one hand the elderly enjoy the greatest absolute benefit from adequate cardiovascular treatment while on the other they might be more susceptible to adverse reactions. In spite of the fact statins represent preventative medications, they must be indicated cautiously taken into consideration comorbidities, frailty and disability occurring in advanced age. Frail and disabled patients have greater risk of statin adverse effects, however, even these patients have lower mortality rates while being on statins. In seniors with life expectancy exceeding 5 years statins, when indicated, bring unambiguously proven benefit and should be considered high-priority medications. Key words: atherosclerosis - cardiovascular disease - dyslipidemia - elderly - frailty - management - statins.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
00:59Gene Therapy
01:26Group Therapy
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:22Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
01:28Drug Therapy
Antianxiety Medications